Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 23786164)

1.

Effect of rosiglitazone, a PPAR-γ ligand on haloperidol-induced catalepsy.

Gupta G, Singh R, David SR, Verma RK.

CNS Neurosci Ther. 2013 Sep;19(9):724-5. doi: 10.1111/cns.12137. Epub 2013 Jun 21. No abstract available.

PMID:
23786164
2.

The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.

Hwang J, Kleinhenz DJ, Rupnow HL, Campbell AG, Thulé PM, Sutliff RL, Hart CM.

Vascul Pharmacol. 2007 Jun;46(6):456-62. Epub 2007 Feb 8.

PMID:
17337254
3.

Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice.

Nair V, Arjuman A, Gopalakrishna HN, Nandini M.

Phytother Res. 2008 Feb;22(2):243-6.

PMID:
17886228
4.

Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease.

Azam F, Barodia SK, Anwer T, Alam MM.

J Enzyme Inhib Med Chem. 2009 Jun;24(3):808-17. doi: 10.1080/14756360802399183.

PMID:
18846462
5.

Antioxidant properties of pioglitazone limit nicotinamide adenine dinucleotide phosphate hydrogen oxidase and augment superoxide dismutase activity in cardiac allotransplantation.

Hasegawa T, Okada K, Okita Y, Pinsky DJ.

J Heart Lung Transplant. 2011 Oct;30(10):1186-96. doi: 10.1016/j.healun.2011.07.006.

PMID:
21962020
6.
7.

Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone.

Henderson BC, Sen U, Reynolds C, Moshal KS, Ovechkin A, Tyagi N, Kartha GK, Rodriguez WE, Tyagi SC.

Int J Biol Sci. 2007 Sep 7;3(6):385-92.

8.

Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease--a historical prospective.

Schmilovitz-Weiss H, Hochhauser E, Cohen M, Chepurko Y, Yitzhaki S, Grossman E, Leibowitz A, Ackerman Z, Ben-Ari Z.

Lipids Health Dis. 2013 Mar 25;12:41. doi: 10.1186/1476-511X-12-41.

9.

[PPAR gamma agonist rosiglitazone alleviates hypoxia/reoxygenation-induced oxidative stress and apoptosis in rat cardiac myocytes].

Yao YJ, Geng DF, Wang JF, Yang MH, Zhang YL, Nie RQ, Zhou SX.

Nan Fang Yi Ke Da Xue Xue Bao. 2009 Apr;29(4):689-93. Chinese.

10.

Effect of NR-ANX-C (a polyherbal formulation) on haloperidol induced catalepsy in albino mice.

Nair V, Arjuman A, Dorababu P, Gopalakrishna HN, Chakradhar Rao U, Mohan L.

Indian J Med Res. 2007 Nov;126(5):480-4.

PMID:
18160755
12.

Rosiglitazone, PPAR-gamma receptor ligand, decreases the viability of rat prolactin-secreting pituitary tumor cells in vitro.

Gruszka A, Kunert-Radek J, Pawlikowski M.

Neuro Endocrinol Lett. 2005 Feb;26(1):51-4.

PMID:
15726020
13.
14.

Activation of cerebral peroxisome proliferator-activated receptors gamma exerts neuroprotection by inhibiting oxidative stress following pilocarpine-induced status epilepticus.

Yu X, Shao XG, Sun H, Li YN, Yang J, Deng YC, Huang YG.

Brain Res. 2008 Mar 20;1200:146-58. doi: 10.1016/j.brainres.2008.01.047. Epub 2008 Jan 26.

PMID:
18289512
15.

Dual PPAR-alpha and -gamma activators derived from novel benzoxazinone containing thiazolidinediones having antidiabetic and hypolipidemic potential.

Madhavan GR, Chakrabarti R, Reddy KA, Rajesh BM, Balraju V, Rao PB, Rajagopalan R, Iqbal J.

Bioorg Med Chem. 2006 Jan 15;14(2):584-91. Epub 2005 Sep 28.

PMID:
16198573
16.

Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.

Wu M, Melichian DS, Chang E, Warner-Blankenship M, Ghosh AK, Varga J.

Am J Pathol. 2009 Feb;174(2):519-33. doi: 10.2353/ajpath.2009.080574. Epub 2009 Jan 15.

17.

INT131: a selective modulator of PPAR gamma.

Motani A, Wang Z, Weiszmann J, McGee LR, Lee G, Liu Q, Staunton J, Fang Z, Fuentes H, Lindstrom M, Liu J, Biermann DH, Jaen J, Walker NP, Learned RM, Chen JL, Li Y.

J Mol Biol. 2009 Mar 13;386(5):1301-11.

PMID:
19452630
18.

Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.

Mishra PK, Tyagi N, Sen U, Joshua IG, Tyagi SC.

Cardiovasc Diabetol. 2010 Sep 9;9:49. doi: 10.1186/1475-2840-9-49.

19.

PPARγ agonist pioglitazone improves scopolamine-induced memory impairment in mice.

Xiang GQ, Tang SS, Jiang LY, Hong H, Li Q, Wang C, Wang XY, Zhang TT, Yin L.

J Pharm Pharmacol. 2012 Apr;64(4):589-96. doi: 10.1111/j.2042-7158.2011.01432.x. Epub 2012 Feb 21.

PMID:
22420664
20.

Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.

Gao DF, Niu XL, Hao GH, Peng N, Wei J, Ning N, Wang NP.

Biochem Pharmacol. 2007 Jan 15;73(2):185-97. Epub 2006 Sep 23.

PMID:
17074304
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk